Bruker Corp (BRKR) Stock Price, Quote & News

Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, inte...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 663 3660

Fax: 978 663 5585

Website: www.bruker.com

Address:

40 Manning Road, Billerica, United States

BillionerOfKing Jan. 14 at 6:13 PM

$BRKR Current Stock Price: $48.95 Contracts to trade: $50 BRKR Jan 16 2026 Call Entry: $1.03 Exit: $1.49 ROI: 44% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

RunnerSignals Jan. 5 at 9:15 PM

Market Warriors Bounce Back $ASTS $HAIN $LVRO $RERE $BRKR all started down but flipped the script today

0 · Reply

ZacksResearch Dec. 26 at 1:17 PM

$BRKR poised for growth, but macro risks loom. ⚠️ With strong prospects in CALID and BSI Nano segments, Bruker is innovating with products like timsOmni and the Dynamic Nuclear Polarization (d-DNP) Polarizer. Yet, macroeconomic challenges, including geopolitical tensions and funding constraints, could impact operations. Find out what this means for investors 👉 https://www.zacks.com/stock/news/2809013/should-you-continue-to-hold-brkr-stock-in-your-portfolio?cid=sm-stocktwits-2-2809013-body-26387&ADID=SYND_STOCKTWITS_TWEET_2_2809013_BODY_26387

0 · Reply

RefinementRanger Dec. 26 at 12:34 PM

$BRKR Risk appetite is present but conditioned on validation. Governance alignment should reduce uncertainty over time. Missteps would reset expectations abruptly. Execution quality will determine whether momentum is sustainable.

0 · Reply

ZacksResearch Dec. 26 at 11:54 AM

Hold or fold on $BRKR? This is a portfolio decision you can’t ignore right now. ⚖️ The question on the table is straightforward: should you continue to hold BRKR stock in your portfolio — or is it time to rethink the position? Get the full hold vs. move-on breakdown here 👉 https://www.zacks.com/stock/news/2809013/should-you-continue-to-hold-brkr-stock-in-your-portfolio?cid=sm-stocktwits-2-2809013-teaser-26356&ADID=SYND_STOCKTWITS_TWEET_2_2809013_TEASER_26356

0 · Reply

OfficialStocktwitsUser Dec. 25 at 6:21 PM

$BRKR RSI: 49.21, MACD: 1.0777 Vol: 1.49, MA20: 46.89, MA50: 43.11 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

LeaRoss Dec. 24 at 3:27 PM

$BRKR healthcare tools steady grind higher low drama trend

0 · Reply

JerseyJumper Dec. 24 at 12:45 PM

$BRKR Current positioning will be tested as management navigates capital constraints while advancing core initiatives. Sustained traction would support a meaningful re-rating.

0 · Reply

PLTRLONGDONG Dec. 18 at 5:05 PM

$ABCL so does this mean $BRKR can still use the microfluidic tech? just has to pay us?

0 · Reply

AStrokeOfLuck Dec. 18 at 3:01 PM

$ABCL $BRKR

0 · Reply

Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 9, 2026, 7:00 AM EST - 5 days ago

Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI

Jan 9, 2026, 6:07 AM EST - 5 days ago

Bruker: Attractive Valuation Ahead Of An Earnings Inflection

Jan 8, 2026, 7:00 AM EST - 6 days ago

Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets

Jan 7, 2026, 4:01 PM EST - 7 days ago

Bruker Corporation to Present at the J.P. Morgan Healthcare Conference

Dec 22, 2025, 10:04 AM EST - 23 days ago

RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)

Dec 10, 2025, 7:00 AM EST - 5 weeks ago

Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions

Dec 10, 2025, 6:52 AM EST - 5 weeks ago

Bruker Corporation (BRKR) Presents at 53rd Annual Nasdaq Investor Conference Transcript

Dec 8, 2025, 8:00 AM EST - 5 weeks ago

Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026

Nov 24, 2025, 9:00 AM EST - 7 weeks ago

Indaba Capital Announces Sale of AST Revolution to Bruker

Nov 10, 2025, 7:45 PM EST - 2 months ago

Q3 2025 Portfolio: Focusing On Resilience, Attractive Valuation And Sound Capital Allocation

AB EQH FISV GOOG GOOGL NEU ODFL

Nov 4, 2025, 4:01 PM EST - 2 months ago

Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend

Nov 3, 2025, 12:46 PM EST - 2 months ago

Bruker Corporation (BRKR) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 7:00 AM EST - 2 months ago

Bruker Reports Third Quarter 2025 Financial Results

Oct 22, 2025, 4:05 PM EDT - 3 months ago

Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast

Oct 3, 2025, 7:00 AM EDT - 3 months ago

Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University

Oct 2, 2025, 4:27 AM EDT - 3 months ago

New Preferred Stock And Baby Bond IPOs, September 2025

AGNC CIM GECC RITM WSBC

Sep 9, 2025, 6:25 PM EDT - 4 months ago

BRUKP: Bruker Corp 6.375% Mandatory Convertible Preferred Stock IPO

Sep 3, 2025, 11:37 PM EDT - 4 months ago

Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock

Sep 3, 2025, 8:17 AM EDT - 4 months ago

Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

MLYS

Sep 2, 2025, 4:01 PM EDT - 4 months ago

Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock

Aug 15, 2025, 3:31 AM EDT - 5 months ago

Bruker: Former Academia Customer Strength, Now Incredible Weakness

Aug 12, 2025, 7:00 AM EDT - 5 months ago

Bruker Announces Quarterly Dividend

Aug 6, 2025, 8:00 AM EDT - 5 months ago

Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors

Aug 5, 2025, 1:46 PM EDT - 5 months ago

These Analysts Slash Their Forecasts On Bruker After Weaker-Than-Expected Q2 Results

Aug 5, 2025, 7:12 AM EDT - 5 months ago

Bruker Stock: Caution Warranted Despite Bullish Analyst Calls

Aug 4, 2025, 12:45 PM EDT - 5 months ago

Bruker Corporation (BRKR) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:00 AM EDT - 5 months ago

Bruker Reports Second Quarter 2025 Financial Results

Jul 21, 2025, 8:00 AM EDT - 6 months ago

Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025

Jun 24, 2025, 7:00 AM EDT - 7 months ago

Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands

Jun 3, 2025, 11:00 AM EDT - 8 months ago

Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection

Jun 3, 2025, 7:00 AM EDT - 8 months ago

Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics

Jun 2, 2025, 7:01 AM EDT - 8 months ago

Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics

Jun 2, 2025, 7:00 AM EDT - 8 months ago

Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity

May 30, 2025, 4:31 PM EDT - 8 months ago

Bruker Corporation to Present at the Jefferies Global Healthcare Conference

May 30, 2025, 8:00 AM EDT - 8 months ago

Bruker Launches Revolutionary timsOmniTM Mass Spectrometer

May 30, 2025, 7:00 AM EDT - 8 months ago

Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidence - at Speed, Depth, and Scale

May 28, 2025, 7:00 AM EDT - 8 months ago

Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology

May 14, 2025, 7:00 AM EDT - 8 months ago

Bruker and 10x Genomics Reach Global Settlement of Patent Litigation

May 7, 2025, 1:12 PM EDT - 9 months ago

Bruker Corporation (BRKR) Q1 2025 Earnings Call Transcript

May 7, 2025, 7:00 AM EDT - 9 months ago

Bruker Reports First Quarter 2025 Financial Results

Apr 25, 2025, 7:00 AM EDT - 9 months ago

Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025

Apr 24, 2025, 7:30 AM EDT - 9 months ago

Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis

Apr 23, 2025, 6:15 AM EDT - 9 months ago

Solis Agrosciences Names Crystal Winkeler Chief Business Officer to Drive Commercial Growth

Apr 17, 2025, 9:00 AM EDT - 9 months ago

Bruker Introduces nVista 2P Miniature Microscope

Apr 16, 2025, 6:00 AM EDT - 9 months ago

Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring

Apr 11, 2025, 10:17 AM EDT - 9 months ago

Why Is Life Science Focused Bruker Stock Trading Higher On Friday?

Apr 11, 2025, 8:00 AM EDT - 9 months ago

Bruker Announces First Quarter 2025 Preliminary Revenue

Apr 11, 2025, 6:00 AM EDT - 9 months ago

Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing

Apr 7, 2025, 7:01 AM EDT - 10 months ago

Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System

BillionerOfKing Jan. 14 at 6:13 PM

0 · Reply

RunnerSignals Jan. 5 at 9:15 PM

Market Warriors Bounce Back $ASTS $HAIN $LVRO $RERE $BRKR all started down but flipped the script today

0 · Reply

ZacksResearch Dec. 26 at 1:17 PM

0 · Reply

RefinementRanger Dec. 26 at 12:34 PM

0 · Reply

ZacksResearch Dec. 26 at 11:54 AM

0 · Reply

OfficialStocktwitsUser Dec. 25 at 6:21 PM

0 · Reply

LeaRoss Dec. 24 at 3:27 PM

$BRKR healthcare tools steady grind higher low drama trend

0 · Reply

JerseyJumper Dec. 24 at 12:45 PM

$BRKR Current positioning will be tested as management navigates capital constraints while advancing core initiatives. Sustained traction would support a meaningful re-rating.

0 · Reply

PLTRLONGDONG Dec. 18 at 5:05 PM

$ABCL so does this mean $BRKR can still use the microfluidic tech? just has to pay us?

0 · Reply

AStrokeOfLuck Dec. 18 at 3:01 PM

$ABCL $BRKR

0 · Reply

JarvisFlow Dec. 15 at 8:56 PM

Barclays updates rating for Bruker ( $BRKR ) to Overweight, target set at 45 → 55.

0 · Reply

JarvisFlow Dec. 15 at 7:04 PM

JP Morgan updates rating for Bruker ( $BRKR ) to Overweight, target set at 50 → 55.

0 · Reply

JarvisFlow Dec. 15 at 6:22 PM

Wells Fargo updates rating for Bruker ( $BRKR ) to Overweight, target set at 48 → 55.

0 · Reply

JarvisFlow Dec. 15 at 1:18 PM

B of A Securities has updated their rating for Bruker ( $BRKR ) to Buy with a price target of 60.

0 · Reply

JarvisFlow Dec. 10 at 4:31 PM

Wolfe Research has updated their rating for Bruker ( $BRKR ) to Outperform with a price target of 60.

0 · Reply

erevnon Dec. 9 at 2:48 PM

Goldman Sachs initiates coverage on Bruker $BRKR at Sell rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

JarvisFlow Dec. 9 at 12:43 PM

Goldman Sachs has updated their rating for Bruker ( $BRKR ) to Sell with a price target of 40.

0 · Reply

BillionerOfKing Dec. 5 at 11:22 AM

$BRKR Current Stock Price: $48.39 Contracts to trade: $50 BRKR Dec 19 2025 Call Entry: $1.17 Exit: $1.50 ROI: 28% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Estimize Dec. 3 at 1:09 PM

Wall St is expecting 0.65 EPS for $BRKR Q4 [Reporting 02/17 BMO] http://www.estimize.com/intro/brkr?chart=historical&metric_name=eps&utm_co

0 · Reply

BEATOFtheMARKET Dec. 2 at 10:16 AM

$BRF $BRKR $BRO $BRX $BRZU

0 · Reply

stockanalysis_ Nov. 25 at 10:34 PM

After Hours Losers: $KXIN $BRKR $NTNX $VERA $AZI Bookmark this page: https://stockanalysis.com/markets/afterhours/losers/?ref=saveontrading

1 · Reply

BEATOFtheMARKET Nov. 25 at 2:31 PM

$BRF $BRKR $BRO $BRX $BRZU

0 · Reply

Market Cap	8.12B
Revenue (ttm)	3.37B
Net Income (ttm)	113.10M
EPS (ttm)	N/A
PE Ratio	27.23
Forward PE	25.31
Profit Margin	3.36%
Debt to Equity Ratio	0.82

Volume	2,995,668
Avg Vol	2,434,470
Day's Range	N/A - N/A
Shares Out	151.94M
Stochastic %K	43%
Beta	1.17
Analysts	Sell
Price Target	$53.14